Elequin Capital »

Ligand Pharmaceuticals In shares owned by Elequin Capital

Quarter-by-quarter ownership of Ligand Pharmaceuticals In (LGND) shares owned by Elequin Capital from 13F filings

Historical chart of Elequin Capital investment in Ligand Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Ligand Pharmaceuticals In held by Elequin Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ligand Pharmaceuticals In by Elequin Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $6.4k 34 189.06
2022-03-31 $999 9 111.11

More positions owned by Elequin Capital

NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Microsoft Corporation Put Option (MSFT)
Axon Enterprise Note 0.500%12/1 (Principal)
Amazon Put Option (AMZN)
Bitwise Solana Staking Etf Com Shs Of Benef (BSOL)
Advanced Micro Devices (AMD)
Broadcom Put Option (AVGO)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple Put Option (AAPL)
Box Note 1/1 (Principal)
Grayscale Solana Tr Etf SHS (GSOL)
Expedia Group Note 2/1 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int Call Option (IBIT)
Bitwise Bitcoin Etf Tr Shs Ben Int (BITB)

View all positions for Elequin Capital

Top funds holding Ligand Pharmaceuticals In

BlackRock
Vanguard Group
Henderson Group
State Street Corporation
Chicago Capital
Invesco
Massachusetts Financial Services
Stephens Investment Management Group
Franklin Resources
Geode Capital Management
Congress Asset Management
FMR
Dimensional Fund Advisors
Goldman Sachs Group
Loomis, Sayles and

View all funds holding Ligand Pharmaceuticals In